Search
ETOPOSIDE MYLAN 20 MG / ML, Solution pour perfusion
Details
| --- | Description |
|---|---|
| Pack | Boîte de 10 flacons de 10 ml |
| Strength (Dosage) | |
| Laboratory | SYNTHEMEDIC |
| Ingredients | Etoposide |
| Therapeutic class | Cytostatique, dérivé de la podophyllotoxine |
| ATC code | L01CB01 |
| PPH | $120.00 |
| PPV | $146.50 |
| Refundable | Yes |
| Refund base | $146.50 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | En association avec d'autres cytostatiques ou en monothérapie pour traiter la leucémie myéloïde aiguë, la maladie de Hodgkin, les lymphomes non hodgkiniens à un stade avancé, le cancer du poumon à petites cellules ou les tumeurs germinales; dans le cadre de schémas de réserve pour traiter d'autres cancers tels que le choriocarcinome ou le cancer du poumon non à petites cellules. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem